Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at ...

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

These four technologies won’t be on our 2026 list of breakthroughs, but all were closely considered, and we think they’re ...

Citi Annual Global Healthcare Conference 2025 December 3, 2025 4:00 PM ESTCompany ParticipantsMarshall Fordyce - ...

Texas lawmakers heard conflicting reports on the state’s readiness to fight the New World Screwworm, which is approaching the ...

Explore how the future of obesity drugs starts in preclinical discovery, addressing global challenges and advancing treatment options.

November's wave of FDA oncology approvals signals the industry's shift toward platform-based precision therapies over broad-spectrum approaches([1]) . The global anticancer drug market now values ...

Neurocrine Biosciences, Inc. ( NBIX) Discusses Progress and Strategy in Neurology and Obesity R&D Programs December 16, 2025 12:00 PM EST ...

Dispersing federal research funding, largely concentrated at private universities on the coasts, to the rest of the country ...

Nothing corrodes public trust in a regulatory agency faster than the sense that its senior officials are auditioning for ...

Exploration of key clinical trial data and real-world evidence on dupilumab in asthma and COPD presented at the ERS and CHEST ...